Menu

Filters

  • Result Found In

Small-Clinical-Analyzers - Henry Schein Medical

Small-Clinical-Analyzers - Henry Schein Medical

Register Now
Login
Request Info

Cholestech LDX®

The Cholestech LDX® System makes it possible to provide a complete lipid profile with tests for total cholesterol (TC), HDL & LDL cholesterol, triglycerides, and glucose (GLU), as well as tests for ALT and AST (for liver enzyme monitoring), and high sensitivity C-reactive protein (hs-CRP)-all done in five minutes per test cassette (seven minutes for CRP).

The accuracy, speed, and broad menu of tests available for the LDX System make it an invaluable tool in recognizing the risks of coronary disease, diabetes, and metabolic syndrome.

The LDX System is comprised of a small, portable desktop analyzer and a toolbox of different test cassettes; Lipid Profile •GLU, TC•HDL•GLU, TC•HDL, TC• GLU, TC, ALT•AST, and hs-CRP.

  Cholestech LDX®

Triage® Meters

Triage® Meters are designed to provide diagnostic results quickly and easily. Quantitative diagnostic panel results are displayed and printed in easy to read numbers and highlighted when the result is above the cutoff. Qualitative diagnostic panel results are displayed as positive (POS) or negative (NEG), eliminating the need for interpretation of lines that often hamper qualitative diagnostics.

Cardiovascular Diseases

  • Triage® BNP Test
    An immunoassay that measures B-type Natriuretic Peptide (BNP) in whole blood or plasma, used:
    • as an aid in the diagnosis of CHF
    • as an aid in the assessment of severity of CHF
    • for the risk stratification of patients with ACS
    • for the risk stratification of patients with HF
  • Triage® Cardiac Panel
    An immunoassay for the quantitative determination of CK-MB, myoglobin, and troponin I in whole blood or plasma, as an aid in the diagnosis of acute myocardial infarction.
  • Triage® CardioProfilER® Panel
    An immunoassay for use as an aid in the diagnosis of acute myocardial infarction, the diagnosis and assessment of severity of congestive heart failure, and the risk stratification of patients with acute coronary syndromes and congestive heart failure. One panel combines troponin I, CK-MB, myoglobin, and BNP to provide rapid, accurate results in whole blood and plasma.
  • Triage® Profiler S.O.B.™ Panel
    An immunoassay for use as an aid in the diagnosis of myocardial infarction, the diagnosis and assessment of severity of heart disease, the assessment and evaluation of patients suspected of having disseminated intravascular coagulation and thromboembolic events including pulmonary embolism and DVT, and the risk stratification of patients with acute coronary syndromes and congestive heart failure. One panel combines BNP, CK-MB, D-dimer, myoglobin, and troponin I.
  • Triage® D-Dimer Test
    An immunoassay for use as an aid in the assessment and evaluation of patients suspected of having disseminated intravascular coagulation or thromboembolic events including pulmonary embolism (PE).

Drug Screening

  • Triage® TOX Drug Screen
    A fluorescence immunoassay intended to be used with the Triage® Meters for the point-of-care qualitative determination of major metabolites of amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, opiates, phencyclidine, THC, and trycylic antidepressants in urine.
  Triage® Meters

CLINITEK Status®+ Analyzer

The new CLINITEK Status+ Analyzer features new automatic checks (Auto-Checks*). The analyzer automatically checks each test strip for humidity exposure and identifies Siemens test strips. Together, these provide improved clinical information.

  • Enhances confidence in clinical decisions with new automated checks (Auto-Checks) performed on every test
  • Ensures consistent results interpretation with automatic timing and reading of every urine specimen
  • Ready for connectivity to data-management solutions (DMS), via a simple upgrade kit
  • Offers a comprehensive point-of-care urinalysis menu for routine testing, detection of early kidney disease, and hCG pregnancy testing
  • CLIA-waived
  CLINITEK Status®+ Analyzer

DCA Vantage® Analyzer

Deliver Optimal Diabetes Care with Clinical Confidence Drive diabetes patient compliance using the DCA Vantage Analyzer with clinically proven HbA1c1, Albumin and Creatinine tests and Albumin-to-Creatinine (A:C) ratio results. Simple enough to use in your office or clinic, and yet powerful enough to deliver lab-quality performance at the point of care.

  • Only 1uL of whole blood needed for HbA1c testing
  • HbA1c results in 6 minutes. Receive actionable results during the patient visit reducing follow-up time and increasing diabetes patient compliance
  • Microalbumin testing allows for early detection of kidney disease – results available in 7 minutes
  • No sample or reagent preparation needed allowing for simple and efficient operation
  • Printed patient records and electronic transmission to LIS or electronic medical record allows for reduced transcription errors
  • Trending graphs enable more comprehensive patient disease management

The analyzer leverages robust technology and delivers the proven performance of the DCA HbA1c and DCA Microalbumin/Creatinine tests highlighted in over 100 clinical articles. Provide the clinical confidence you and your patients deserve by adopting the DCA Vantage system, the analyzer used by three out of four physicians who perform HbA1c testing. In-office.

Contact us for more information:
Phone: 1-800-772-4346, 8am-8:30pm ET
E-mail: medsls@henryschein.com

  DCA Vantage® Analyzer